HKD 1.16
(0.0%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 364.24 Million CNY | -20.13% |
2022 | 456.06 Million CNY | -18.84% |
2021 | 561.92 Million CNY | 4.83% |
2020 | 536.01 Million CNY | -11.48% |
2019 | 605.53 Million CNY | 51.79% |
2018 | 398.93 Million CNY | -28.31% |
2017 | 556.48 Million CNY | 83.7% |
2016 | 302.93 Million CNY | 47.94% |
2015 | 204.76 Million CNY | 15.97% |
2014 | 176.56 Million CNY | 0.67% |
2013 | 175.38 Million CNY | -9.04% |
2012 | 192.81 Million CNY | -15.64% |
2011 | 228.58 Million CNY | 7.94% |
2010 | 211.77 Million CNY | -15.34% |
2009 | 250.13 Million CNY | -14.28% |
2008 | 291.79 Million CNY | -33.9% |
2007 | 441.44 Million CNY | 119.49% |
2006 | 201.12 Million CNY | 23.61% |
2005 | 162.71 Million CNY | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 478.78 Million CNY | 0.0% |
2023 Q4 | 364.24 Million CNY | 0.0% |
2023 FY | 364.24 Million CNY | -20.13% |
2023 Q2 | 495.59 Million CNY | 0.0% |
2022 FY | 456.06 Million CNY | -18.84% |
2022 Q2 | 631.17 Million CNY | 0.0% |
2022 Q4 | 456.06 Million CNY | 0.0% |
2021 Q4 | 561.92 Million CNY | 0.0% |
2021 FY | 561.92 Million CNY | 4.83% |
2021 Q2 | 506.23 Million CNY | 0.0% |
2020 Q4 | 536.01 Million CNY | 0.0% |
2020 FY | 536.01 Million CNY | -11.48% |
2020 Q2 | 554.58 Million CNY | 0.0% |
2019 FY | 605.53 Million CNY | 51.79% |
2019 Q2 | 377.63 Million CNY | 0.0% |
2019 Q4 | 605.53 Million CNY | 0.0% |
2018 Q2 | 488.1 Million CNY | 0.0% |
2018 Q4 | 398.93 Million CNY | 0.0% |
2018 FY | 398.93 Million CNY | -28.31% |
2017 FY | 556.48 Million CNY | 83.7% |
2017 Q4 | 556.48 Million CNY | 0.0% |
2017 Q2 | 391.73 Million CNY | 0.0% |
2016 Q2 | 235.55 Million CNY | 0.0% |
2016 FY | 302.93 Million CNY | 47.94% |
2016 Q4 | 302.93 Million CNY | 0.0% |
2015 Q4 | 204.76 Million CNY | 0.0% |
2015 Q2 | 216.09 Million CNY | 0.0% |
2015 FY | 204.76 Million CNY | 15.97% |
2014 FY | 176.56 Million CNY | 0.67% |
2014 Q2 | 165.44 Million CNY | 0.0% |
2014 Q4 | 176.56 Million CNY | 0.0% |
2013 Q2 | 281.4 Million CNY | 0.0% |
2013 FY | 175.38 Million CNY | -9.04% |
2013 Q4 | 175.38 Million CNY | 0.0% |
2012 Q2 | 215.96 Million CNY | 0.0% |
2012 Q4 | 192.81 Million CNY | 0.0% |
2012 FY | 192.81 Million CNY | -15.64% |
2011 Q2 | 234.92 Million CNY | 0.0% |
2011 FY | 228.58 Million CNY | 7.94% |
2011 Q4 | 228.58 Million CNY | 0.0% |
2010 Q2 | 218.36 Million CNY | 0.0% |
2010 FY | 211.77 Million CNY | -15.34% |
2010 Q4 | 211.77 Million CNY | 0.0% |
2009 FY | 250.13 Million CNY | -14.28% |
2009 Q4 | 250.13 Million CNY | 0.0% |
2009 Q2 | 289.56 Million CNY | 0.0% |
2008 Q4 | 291.79 Million CNY | 0.0% |
2008 FY | 291.79 Million CNY | -33.9% |
2007 FY | 441.44 Million CNY | 119.49% |
2006 FY | 201.12 Million CNY | 23.61% |
2005 FY | 162.71 Million CNY | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Wai Chun Bio-Technology Limited | 229.69 Million HKD | -58.578% |
Lee & Man Chemical Company Limited | 1.22 Billion HKD | 70.368% |